Events

Reset
  • 09/07/2019

    Arecor signs a new formulation evaluation agreement with an existing partner, a major global pharmaceutical company

  • 07/05/2019

    Proactive Investors INTERVIEW with Sarah Howell

  • 07/05/2019

    First Patient Dosing In Phase I Clinical Trial 7May2019